| Patient | Emile Griffith |
|---|---|
| Date of birth | 1938-02-03 |
| Identifiers | MRN HR-BX005-SYN-TD; SSN (made up) 000-05-6418 |
| Document date | 2005-10-27 |
| Author | Celeste Fairbanks-Ochieng, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Six-month review of PTSD, mood and memory. [S]
Emile Griffith returns with his care partner. Nightmares come about once every two weeks, and he sleeps about six and a half hours most nights. He takes sertraline 50 mg each morning without side effects and asks how long he should stay on it. He walks most mornings, does his exercises and has had no falls. He visited a boxing gym in the city twice this month to watch young fighters train. His care partner has noticed no change in his memory, and he has not been lost. No thoughts of suicide. [S]
| Element | Detail |
|---|---|
| PCL-5 | 20, from 41 at intake |
| PHQ-9 | 4; item 9 scored 0 |
| Nightmares | About once every two weeks |
| Falls | None; Timed Up and Go 10 seconds |
| Vaccines today | High-dose influenza and the second zoster dose |
| System | Result | Finding |
|---|---|---|
| Psychiatric | Positive | Occasional nightmares; mood good; no thoughts of suicide |
| Neurological | Positive | Forgetfulness unchanged; no headaches, weakness, tremor or slowness |
| Constitutional | Negative | Weight stable; no fatigue |
| Musculoskeletal | Negative | No falls |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 25 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 2005-05-05 to 2005-06-16 | completed | S |
| Sertraline 50 mg oral tablet, one tablet each morning | One tablet each morning | Oral route | 2005-06-16 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2005-10-27 | Body height | 170 | cm | S |
| 2005-10-27 | Body weight | 74.2 | kg | S |
| 2005-10-27 | Body mass index (BMI) [Ratio] | 25.7 | kg/m2 | S |
| 2005-10-27 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2005-10-27 | Diastolic blood pressure | 76 | mm[Hg] | S |
| 2005-10-27 | Heart rate | 66 | /min | S |
| 2005-10-27 | Respiratory rate | 14 | /min | S |
| 2005-10-27 | Body temperature | 36.6 | Cel | S |
| 2005-10-27 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2005-10-27 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 4 | {score} | S | ||
| 2005-10-27 | PTSD PCL-5 score [PCL-5] | 20 | {score} | S |
Vital signs recorded on 2005-10-27; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well and cheerful; blood pressure 126/76 mmHg; pulse 66; weight 74.2 kg |
| Musculoskeletal | Timed Up and Go 10 seconds |
| Mental status | Euthymic; tells stories with fewer repetitions; no psychotic symptoms; denies thoughts of suicide |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Memory loss and confusion over about a year, worse in recent months, reported by him and his care partner: repeating stories and questions, losing the thread of conversations, mixing up days, two missed appointments, and once getting lost changing trains on a familiar route; cause to be found | resolved | confirmed | R41.3 | S — Synthetic presenting problem anchored to the documented short-term memory problems; resolved into the diagnosis at the third visit. Not a claim about his real symptoms at that age. |
| Post-traumatic stress disorder, chronic, after two index events (a title fight decades ago after which his opponent died, and a severe assault thirteen years ago): nightmares, unwanted images, avoidance of fight footage, guilt and self-blame, being on guard in crowds, poor sleep; PCL-5 41 | active | confirmed | F43.12 | S — Synthetic modern diagnosis at intake by clinical interview against DSM-5-TR criteria, anchored to his public words about lifelong nightmares; not a historical diagnosis. |
| Mild cognitive impairment (mild neurocognitive disorder) with slowed processing, executive and memory-retrieval deficits, most likely due to traumatic brain injury from a nineteen-year professional boxing career and a severe assault; meets the NINDS research criteria for traumatic encephalopathy syndrome (a research diagnosis); Alzheimer's disease co-pathology not excluded | active | confirmed | G31.84 | S — Synthetic modern diagnosis at the third visit after MRI and neuropsychological testing; anchored to the documented memory problems and pugilistic dementia, not a retrospective diagnosis of his real illness. |
| Personal history of traumatic brain injury: repetitive head impacts over 112 professional bouts, and a severe head injury in an assault thirteen years ago with months in hospital | active | confirmed | Z87.820 | S — Synthetic coding of the documented career and assault. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | Cognitive testing (MoCA) | At diagnosis, then yearly, or sooner with change | Up to date | MoCA 22 at intake; next at the yearly review in about six months |
| Survey | Staging (CDR) and function (ADL and IADL) | At diagnosis, then yearly | Up to date | CDR 0.5 at two weeks; function unchanged |
| Survey | Neuropsychological testing | At diagnosis when the cause or stage is unclear; repeat in 12 to 18 months or with change | Up to date | Repeat due in about a year |
| Examination | Medicine review for anticholinergic, sedating and fall-risk drugs (Beers) | Every visit | Completed today | Sertraline 50 mg only |
| Survey | Neuropsychiatric symptom screen (apathy, irritability, paranoia, impulsivity) | Every visit | Completed today | No apathy, irritability, paranoia or impulsive behavior |
| Survey | PHQ-9 with suicide-risk review (item 9 and structured questions) | Monthly during acute treatment; every visit during active treatment | Completed today | PHQ-9 4 (remission), item 9 scored 0; no thoughts of suicide |
| Survey | PCL-5 | Baseline, then at each chronic-care visit during treatment; response judged after 8 to 12 weeks | Completed today | PCL-5 20 |
| Medication safety | Sertraline: nausea, sleep, falls, bleeding, and sodium (SSRIs can lower sodium in older adults) | Two weeks after starting and after each dose change; sodium at those points | Up to date | No dose change; no side effects; sodium 137 mmol/L six weeks ago |
| Examination | Fall risk (Timed Up and Go, gait and balance), STEADI | At diagnosis, yearly, and after any fall | Completed today | Timed Up and Go 10 seconds; no falls |
| Self-management | Travel, money and home safety | At diagnosis and each follow-up | Completed today | No episodes of getting lost; plans unchanged |
| Survey | Care partner support and burden (Zarit Burden Interview, narrative) | At diagnosis, then every 6 to 12 months | Completed today | Zarit 10 (little or no burden), from 14 |
| Self-management | Advance care planning | At diagnosis; revisit yearly and at changes | Up to date | Health care proxy on file; revisit at the next annual wellness visit |
| Examination | Vascular risk factors (blood pressure, weight) | Every visit | Completed today | Blood pressure 126/76 mmHg; weight 74.2 kg |
Goal progress:
Immunizations given today: High-dose influenza vaccine, 2005-2006 season; Recombinant zoster vaccine, dose 2 of 2 [S]
Guideline basis: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); STEADI (Stopping Elderly Accidents, Deaths and Injuries): Clinical Resources (2024); Adult Immunization Schedule by Age (2026)
Follow-up: Yearly cognitive review with MoCA and CDR in about six months, and the annual wellness visit. COVID-19 vaccine at the pharmacy next week, at his choice. Call the clinic or 988 at any time if thoughts of suicide arise. [S]